Heba Abdelrasheed Allam

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Cerebrospinal Fluid

Top Venues

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Basant T Ibrahim, Heba Abdelrasheed Allam, Nehad M El-Dydamony, Marwa Ahmed Fouad, Eman R Mohammed
Exploring new quinazolin-4(3H)-one derivatives as CDK2 inhibitors: Design, synthesis, and anticancer evaluation. Drug development research 85 (2) (2024)
Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious, Walaa R Mahmoud, Mohanad M Odeh, Hany S Ibrahim, Hatem A Abdel-Aziz, Eman R Mohammed
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug development research 85 (3) (2024)
Dana M Odeh, Heba Abdelrasheed Allam, Fady Baselious, Walaa R Mahmoud, Mohanad M Odeh, Hany S Ibrahim, Hatem A Abdel-Aziz, Eman R Mohammed
Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug development research 85 (3) (2024)
Manal Abdel Fattah Ezzat, Sara Mohamed Abdelhamid, Marwa Ahmed Fouad, Hatem A Abdel-Aziz, Heba Abdelrasheed Allam
Design, synthesis, in vitro, and in vivo evaluation of novel phthalazinone-based derivatives as promising acetylcholinesterase inhibitors for treatment of Alzheimer's disease. Drug development research (2023)